Non-invasive Detection of HER2 Expression by Al18F-NOTA-HER2 Affibody in Gastric Cancer Xenografts

被引:0
|
作者
Han, Jingya [1 ]
Zhao, Xinming [1 ]
Chen, Yang [1 ]
Zhang, Jingmian [1 ]
Wang, Jianfang [1 ]
机构
[1] Hebei Med Univ, Hosp 4, Dept Nucl Med, Shijiazhuang, Hebei, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1081
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Pre-Clinical Study of the [18F]AlF-Labeled HER2 Affibody for Non-Invasive HER2 Detection in Gastric Cancer
    Han, Jingya
    Chen, Yang
    Zhao, Yan
    Zhao, Xinming
    Zhang, Jingmian
    Wang, Jianfang
    Zhang, Zhaoqi
    FRONTIERS IN MEDICINE, 2022, 9
  • [2] Al18F-NOTA-HER2-BCH affibody PET imaging accurately map HER2 positive lesions of breast cancer
    Guo, Xiaoyi
    Zhou, Nina
    Liu, Jiayue
    Zhu, Hua
    Yang, Zhi
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [3] Two HER2 PET tracers: Al18F-NOTA-HER2-BCH and Al18F-RESCA-HER2-BCH were compared
    Liu, Jiayue
    Guo, Xiaoyi
    Wen, Li
    Wang, Lixin
    Ding, Jin
    Liu, Futao
    Zhu, Hua
    Yang, Zhi
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S201 - S202
  • [4] Non-Invasive Monitoring of HER2 Expression in Breast Cancer Patients with 99mTc-Affibody SPECT/CT
    Cai, Jiong
    Li, Xin
    Mao, Feng
    Wang, Pan
    Luo, Yaping
    Zheng, Kun
    Li, Fang
    Zhu, Zhaohui
    IRANIAN JOURNAL OF RADIOLOGY, 2020, 17 (01)
  • [5] Imaging of HER2 expression with F-18-labeled Affibody molecules in a mouse model for ovarian cancer
    Heskamp, S.
    Laverman, P.
    Rosik, D.
    Boschetti, F.
    Oyen, W. J. G.
    van Laarhoven, H. W. M.
    Tolmachev, V.
    Boerman, O. C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S179 - S179
  • [6] Changes in HER2 Expression in Breast Cancer Xenografts After Therapy Can Be Quantified Using PET and 18F-Labeled Affibody Molecules
    Kramer-Marek, Gabriela
    Kiesewetter, Dale O.
    Capala, Jacek
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (07) : 1131 - 1139
  • [7] Affibody-based molecular probe 99mTc-(HE)3ZHER2:V2 for non-invasive HER2 detection in ovarian and breast cancer xenografts
    Hu, Xianwen
    Hu, Hongyu
    Li, Dandan
    Wang, Pan
    Cai, Jiong
    OPEN MEDICINE, 2024, 19 (01):
  • [8] PET of HER2 Expression with a Novel 18FAl Labeled Affibody
    Xu, Yuping
    Bai, Zhicheng
    Huang, Qianhuan
    Pan, Yunyun
    Pan, Donghui
    Wang, Lizhen
    Yan, Junjie
    Wang, Xinyu
    Yang, Runlin
    Yang, Min
    JOURNAL OF CANCER, 2017, 8 (07): : 1170 - 1178
  • [9] Non-invasive HER2 status diagnosis in gastric cancer using surrogate DNA methylation markers
    Liu, X.
    Ye, G.
    Lei, X.
    Li, H.
    Yang, T.
    Chen, S.
    Yu, Y.
    Chen, X.
    Zhang, G.
    Sun, H.
    Bibikova, M.
    Cui, C.
    Chen, Z.
    Fan, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S264 - S265
  • [10] Evaluating the effect of the chelator on biodistribution of a HER2 imaging agent: DOTA conjugated anti-HER2 Affibody molecule outperforms NODAGA and NOTA in mice bearing prostate cancer xenografts
    Malmberg, Jennie
    Perols, Anna
    Varasteh, Zohreh
    Altai, Mohamed
    Braun, Alexis
    Sandstrom, Mattias
    Garske, Ulrike
    Tolmachev, Vladimir
    Orlova, Anna
    Karlstrom, Amelie Eriksson
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53